These results were consistent with human SCLC data (Figure 2B), indicating that GSDME could play an antitumor role after cisplatin induction by activating CD4 effector memory T cells and inhibiting regulatory T cells. The gene discussed is GSDME; the disease is small cell lung carcinoma.